Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCMC Markets Regulatory News (CMCX)

Share Price Information for CMC Markets (CMCX)

Share Price is delayed by 15 minutes
Get Live Data
454.00    24.00 (5.58%)
Bid:
452.00
Ask:
453.00
Spread: 1.00 (0.221%)
Market Cap: £1.24b
CMCX Live PriceLast checked at - London Stock Exchange

Intraday CMC Markets Share Chart

FY 2022 Pre-Close Trading Update

8 Apr 2022 07:00

RNS Number : 6952H
CMC Markets Plc
08 April 2022
 

8 April 2022 

CMC Markets Plc 

 

FY 2022 Pre-Close Trading Update  

 

Q4 performance drives net operating income to the top end of guidance  

 

CMC Markets Plc ("CMC" or the "Group"), a leading global provider of online ("D2C") trading and institutional ("B2B") platform technology, today issues a trading update for the period from 1 January 2022 to 31 March 2022 (the "period") ahead of its full year results.  

 

Key Highlights 

 

· FY 2022 net operating income expected to be approximately £280 million, at the top end of guidance and a record performance outside of the pandemic period.

· FY 2022 gross leveraged client income is expected to be approximately £288 million (FY 2021: £335 million, -14% yoy). 

· FY 2022 leveraged trading revenue is expected to be approximately £230 million (FY 2021: £349 million, -34% yoy). 

· FY 2022 non-leveraged trading revenue is expected to be approximately £48 million (FY 2021: £55 million, -12% yoy).  

· £30 million share buyback commenced 15th March 2022.  

· CMC Invest, the UK non-leveraged platform already launched internally. Full market release set for mid-2022. The platform is ahead of schedule and on budget.  

 

Trading Update  

 

Q4 was CMC's strongest quarter of the year leaving net operating income at the top end of guidance at approximately £280 million. Active monthly trading client numbers continue to remain at similar levels as reported earlier in the year. Our APAC stockbroking business finished FY 2022 with record AuA and a record number of annual active clients. 

 

Operating costs for FY 2022, excluding variable remuneration, are expected to be approximately £173 million (FY 2021: £168 million). The increase primarily reflects higher personnel costs to deliver strategic objectives.  

 

 FY 2022 results for the 12 months ended 31 March 2022 will be announced on 9 June 2022.  

 

Share Buyback Programme

 

On 15 March 2022, the Company commenced a share buyback programme of up to £30 million. The Board's decision to undertake the buyback was underpinned by the Company's robust capital position and having considered required ongoing investment in the business. This Buyback Programme forms part of a normal balanced approach to shareholder returns alongside the current dividend policy.

 

The share buyback programme is progressing well and remains on track to be completed no later than 30 June 2023.

 

Business Development

 

CMC has this week delivered the initial internal launch of CMC Invest, our UK non-leveraged platform to our UK staff. This has been achieved ahead of schedule and on budget. The new platform will be made available to the broader market over the coming quarter.

 

In addition, we will be launching a new investment platform in Singapore within a year, as well as considering two other jurisdictions for launch next year as we continue to diversify and expand our geographic footprint through technology, our leveraged institutional offering, and our non-leveraged platforms.

 

FY 2023 will be another year of investment in these strategic initiatives, which aim to deliver future revenue growth. In addition to the incremental investment, FY 2023 costs are expected to grow with higher marketing spend together with further investment in personnel.

 

 

Lord Cruddas, Chief Executive Officer, commented 

 

"I am delighted to report another year of strong performance both strategically and financially. Outside of the pandemic year (Financial year ending March 2021), this is a record net operating income result for the company. The performance reflects the ongoing success of our B2B technology partnerships and focus across our leveraged and non-leveraged businesses.

 

This business continues to change as we look to utilise our technology to enter new markets and expand our non-leveraged offering. I look forward to updating investors as the strategy expands over both the short and long-term."

 

Forward looking statements 

 

This trading update may include statements that are forward looking in nature. Forward looking statements involve known and unknown risks, assumptions, uncertainties, and other factors which may cause the actual results, performance, or achievements of the Group to be materially different from any future results, performance or achievements expressed or implied by such forward looking statements. Except as required by the Listing Rules and applicable law, the Group undertakes no obligation to update, revise or change any forward-looking statements to reflect events or developments occurring after the date such statements are published. 

 

 

Enquiries 

CMC Markets Plc 

James Cartwright Investor Relations  

Euan Marshall, Chief Financial Officer 

investor.relations@cmcmarkets.com 

 

Camarco +44 (0) 20 3757 4994 

Geoffrey Pelham-Lane 

Jennifer Renwick 

 

Notes to Editors 

 

CMC Markets Plc ("CMC"), whose shares are listed on the London Stock Exchange under the ticker CMCX (LEI: 213800VB75KAZBFH5U07), was established in 1989 and is now one of the world's leading online financial trading businesses. The Group serves retail and institutional clients through regulated offices and branches in 12 countries, with a significant presence in the UK, Australia, Germany, and Singapore. CMC Markets offers an award-winning, online, and mobile trading platform, enabling clients to trade up to 10,000 financial instruments across shares, indices, foreign currencies, commodities, and treasuries through contracts for difference ("CFDs"), financial spread bets (in the UK and Ireland only) and, in Australia, access stockbroking services. More information is available at http://www.cmcmarkets.com/group/

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTEALLXEFKAEFA
Date   Source Headline
4th Jun 20267:05 amRNSDirectorate change
4th Jun 20267:00 amRNSPreliminary Results
6th May 20264:45 pmRNSDirector/PDMR Shareholding
8th Apr 20263:49 pmRNSDirector/PDMR Shareholding
24th Mar 202610:00 amRNSDirectorate change
6th Mar 20263:54 pmRNSDirector/PDMR Shareholding
6th Feb 20263:57 pmRNSDirector/PDMR Shareholding
12th Jan 202612:16 pmRNSDirector/PDMR Shareholding
6th Jan 20261:38 pmRNSDirector/PDMR Shareholding
8th Dec 20252:22 pmRNSDirector/PDMR Shareholding
20th Nov 20257:10 amRNSDividend Declaration
20th Nov 20257:00 amRNSInterim Results
6th Nov 20254:55 pmRNSDirector/PDMR Shareholding
3rd Nov 20251:30 pmRNSDirectorate change
7th Oct 20254:02 pmRNSDirector/PDMR Shareholding
29th Sep 20257:00 amRNSWestpac and CMC Extend Strategic Relationship
11th Sep 20259:40 amRNSDirector/PDMR Shareholding
8th Sep 202511:50 amRNSDirector/PDMR Shareholding
5th Sep 202512:14 pmRNSAppointment of Senior Independent Director
19th Aug 20254:22 pmRNSDirector/PDMR Shareholding
19th Aug 20254:20 pmRNSDirector/PDMR Shareholding
7th Aug 20253:59 pmRNSHolding(s) in Company
6th Aug 20254:08 pmRNSDirector/PDMR Shareholding
4th Aug 20251:23 pmRNSDirector/PDMR Shareholding
31st Jul 20253:53 pmRNSDirector/PDMR Shareholding
24th Jul 20251:21 pmRNSResult of AGM
23rd Jul 20255:20 pmRNSDirector/PDMR Shareholding
18th Jul 20252:36 pmRNSDirector/PDMR Shareholding
16th Jul 20254:57 pmRNSDirector/PDMR Shareholding
8th Jul 20253:04 pmRNSDirector/PDMR Shareholding
20th Jun 20255:11 pmRNSNotice of AGM
19th Jun 20254:53 pmRNSDirector/PDMR Shareholding
18th Jun 202512:18 pmRNSDirector/PDMR Shareholding
12th Jun 20259:45 amRNSConfirmation of Dividend Details
6th Jun 20254:07 pmRNSDirector/PDMR Shareholding
5th Jun 202512:48 pmRNSAnnual Financial Report
5th Jun 20257:30 amRNSDividend Declaration
5th Jun 20257:05 amRNSBoard and Directorate Changes
5th Jun 20257:00 amRNSFinal Results
7th May 20253:35 pmRNSDirector/PDMR Shareholding
8th Apr 20252:10 pmRNSDirector/PDMR Shareholding
7th Mar 20254:48 pmRNSDirector/PDMR Shareholding
6th Mar 202512:21 pmRNSDirector/PDMR Shareholding
27th Feb 20253:25 pmRNSDirector/PDMR Shareholding
25th Feb 20257:00 amRNSDirectorate Change
6th Feb 20253:01 pmRNSDirector/PDMR Shareholding
23rd Jan 20257:00 amRNSTrading Update
13th Jan 202510:08 amRNSDirector/PDMR Shareholding
6th Jan 20254:24 pmRNSDirector/PDMR Shareholding
6th Dec 202411:49 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.